Phase 1/2 Study of the Pan-PIM Kinase Inhibitor INCB053914 Alone or in Combination With Standard-of-Care Agents in Patients With Advanced Hematologic Malignancies.

Details

Language :

English

ISSN :

21522650

Volume :

23

Issue :

9

Database :

Complementary Index

Journal :

Clinical Lymphoma, Myeloma & Leukemia

Publication Type :

Academic Journal

Accession number :

176739005

Full Text :

https://doi.org/10.1016/j.clml.2023.05.002